Structure-Engineered Lipid–Mineral Nanoparticles for Ligand-Free Myeloid RNAi Delivery in Alzheimer’s Disease
Authors:
- 5 November 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
Abstract
Peripheral myeloid cells are key regulators of systemic inflammation and promising targets for immune intervention in Alzheimer’s disease (AD). However, selective in vivo small interfering RNA (siRNA) delivery to these cells remains challenging because conventional lipid nanoparticles often exhibit predominant hepatic accumulation and usually require ligand or antibody modification for immune-cell targeting. Here, we report a structure-engineered lipid–mineral nanoparticle platform, termed MCP, for ligand-free myeloid RNA interference (RNAi) delivery. MCP integrates a calcium phosphate mineral phase with a phosphatidic acid-enriched lipid interface, enabling efficient siRNA incorporation. The Ca2+–lipid cooperative architecture promoted macropinocytosis-dependent uptake and preferential siRNA delivery to peripheral myeloid cells in vivo, particularly Ly6Chigh monocytes and macrophages, with enhanced delivery under AD-associated inflammatory conditions. Systemic delivery of MCP carrying siRNA against triggering receptor expressed on myeloid cells 1 (TREM1) attenuated neuroinflammatory and neurodegenerative pathology in an AD mouse model, supporting peripheral myeloid reprogramming as a route to modulate central nervous system (CNS) disease progression. Notably, MCP also achieved efficient TREM1 silencing in AD patient-derived peripheral blood mononuclear cells (PBMCs) and restored TREM1 expression toward healthy-control levels. This work establishes a structure-driven, ligand-free lipid–mineral RNAi platform for peripheral immune intervention in AD.Keywords
Funding Information
- Shanghai Municipal Education Commission (2023ZKZD21)
- Shanghai Science and Technology Development Foundation (23S41900100)
- Shanghai Science and Technology Development Foundation (25S11908500)
- National Natural Science Foundation of China (32201170)
- National Natural Science Foundation of China (32371460)
- National Natural Science Foundation of China (82171358)
- National Natural Science Foundation of China (82473850)
- National Science and Technology Major Project (2026ZD1807200)
This publication has 48 references indexed in Scilit:
- Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's diseaseActa Pharmaceutica Sinica B, 2025
- Phospholipid Membranes as Chemically and Functionally Tunable MaterialsAdvanced Materials, 2024
- Effects of glass–ceramic produced by the sol–gel route in macrophages recruitment and polarization into bone tissue regenerationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2023
- A quantitative view on multivalent nanomedicine targetingAdvanced Drug Delivery Reviews, 2021
- Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular UnitAdvanced Science, 2020
- Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytesAdvanced Drug Delivery Reviews, 2020
- Soluble TREM1 concentrations are increased and positively correlated with total tau levels in the plasma of patients with Alzheimer’s diseaseAging Clinical and Experimental Research, 2019
- A central role for phosphatidic acid as a lipid mediator of regulated exocytosis in apicomplexaFEBS Letters, 2016
- Role of matrix vesicles in biomineralizationBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1975